RÉSUMÉ
ObjectiveTranscription factor NFE2 was observed abnormal expression in myeloproliferative neoplasm (MPN) patients. However, how NFE2 is transcriptionally regulated remains ambiguous. This study aims to explore the elements and molecular mechanisms involved in the transcriptional regulation of NFE2. MethodsActive enhancers were predicted by public NGS data and conformed experimentally via dual luciferase reporter assay. After that, PRO-seq and GRO-seq data was used to detect enhancer RNAs transcribed from these enhancers. RACE was utilized to clone the full length enhancer RNA (eRNA) transcripts, and RT-qPCR was used to measure their expression in different leukemia cell lines as well as the transcript levels during induced differentiation. Finally, to investigate the molecular function of the eRNA, overexpression and knockdown of the eRNA via lentivirus system was performed in K562 cells. ResultsWe identified three enhancers regulating NFE2 transcription, which located at -3.6k, -6.2k and +6.3k from NFE2 transcription start site (TSS) respectively. At the -3.6k enhancer, we cloned an eRNA transcript and characterized that as a lncRNA which was expressed and located in the nucleus in three types of leukemia cell lines. When this lncRNA was overexpressed, expression of NFE2 was upregulated and decreases of K562 cell proliferation and migration ability were observed. While knocking down of this lncRNA, the level of NFE2 decreases correspondingly and the proliferation ability of K562 cells increases accordingly. ConclusionWe identified an enhancer lncRNA that regulates NFE2 transcription positively and suppresses K562 cell proliferation.
RÉSUMÉ
<p><b>OBJECTIVE</b>To develop suitable methods for safety destruction of tetramethylene disulfotetramine (TETS) and the medical wastes polluted by TETS.</p><p><b>METHODS</b>The chemical stability of TETS was evaluated under the conditions of acid, alkali and high temperature. TETS was treated with sodium hydroxide, hydrochloric acid, sulfuric acid and nitric acid under various treatment conditions, i.e. concentration, temperature and time, followed by determining remaining TETS using gas chromatograms to estimating the degradation efficiency of TETS. TETS was put into ampoule and heated under the different conditions of temperature and time. After heat treatment, TETS residue was determined. For evaluating the absorption factor of active carbon to TETS in water and blood, active carbon was added into the water and blood with content of TETS, incubated at room temperature for 24 hours, and then determined the remaining TETS in water and blood.</p><p><b>RESULTS</b>The complete degradation of TETS was achieved by one of the following treatments: heating with 6.0 mol/L hydrochloric acid at 100 degrees C for half an hour, heating with 3.0 mol/L hydrochloric acid or 6.0 mol/L sodium hydroxide at 100 degrees C for 3 hours, mixing with concentrated sulfuric acid or nitric acid at room temperature for 24 hours, and dry heating at 300 degrees C for 4.5 hours. Active carbon showed a marked effectiveness in absorbing the TETS in blood and water, with the mean absorption efficiency of over 90%.</p><p><b>CONCLUSIONS</b>The results of this study suggest that TETS powder should be degraded by acid or alkali, and that the solid medical wastes polluted by TETS should be destroyed at high temperature. For the blood and water having contents of TETS, the active carbon should be used as to absorbing the TETS and then be destroyed at high temperature.</p>